Pricing Log in Create free account

Canton Strategic Holdings, Inc. (CNTN) vs NovaBridge Biosciences (NBP)

Canton Strategic Holdings, Inc. and NovaBridge Biosciences are both Biotechnology companies. Canton Strategic Holdings, Inc. and NovaBridge Biosciences are of similar size ($149.6M and $149.0M). NovaBridge Biosciences has negative trailing earnings, so its P/E is not meaningful; Canton Strategic Holdings, Inc. trades at 9.0×. Across the 9 metrics below, Canton Strategic Holdings, Inc. leads on 5 and NovaBridge Biosciences on 4.

Valuation

Metric CNTN NBP Biotechnology median
P/E 9.01 n/m 8.50
P/S n/m 5.31 9.71
P/B 0.81 0.51 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 1.94 0.64
EV/Sales n/m (3.81) 9.21
Earnings yield 11.10% (38.61%) (33.15%)
Free cash flow yield (6.01%) (89.83%) (25.50%)

Profitability

Metric CNTN NBP Biotechnology median
Gross margin — 31.10% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (43.10%) 0.00% (56.36%)
Return on assets (34.60%) 0.00% (48.04%)
Return on invested capital (8.11%) 0.00% 0.00%

Growth

Metric CNTN NBP Biotechnology median
Revenue growth (TTM) — (91.84%) 6.02%
EPS growth (last fiscal year) 88.10% (77.78%) 30.26%
Revenue growth, 5-year CAGR — (40.00%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTN NBP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 15.70 7.64 4.72
Net debt to EBITDA 0.85 2.26 0.96

Dividend

Metric CNTN NBP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CNTN NBP Biotechnology median
Market cap 149.01m 149.64m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack